LEVIN MARK J
Insider CIK 1180428 · ZFGN 10% owner · CNST 10% owner · EBIO Director, 10% owner · FMI Director, 10% owner · CTMX 10% owner · NRIX 10% owner · MYOK 10% owner · BPMC 10% owner · SAGE 10% owner · ALNA 10% owner · RVMD 10% owner · GBT 10% owner · VYGR Director, 10% owner · JNCE 10% owner · RYTM 10% owner · EDIT 10% owner · FULC Director, 10% owner · NTGN 10% owner · PLRX 10% owner · RLAY 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-11-12 | 2021-11-16 | 1,900,000 | $8.38 | $15.92M | 1,148,780 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | J Other | 2021-11-10 | 2021-11-12 | 1,000,000 | — | $0 | 3,962,202 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | J Other | 2021-09-22 | 2021-09-24 | 1,000,000 | — | $0 | 4,962,202 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-09-15 | 2021-09-17 | 1,750,000 | — | $0 | 2,697,829 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-06-10 | 2021-06-14 | 1,500,000 | — | $0 | 4,447,829 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2021-06-04 | 2021-06-07 | 164,996 | $30.23 | $4.99M | 0 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2021-06-03 | 2021-06-07 | 378,117 | $30.20 | $11.42M | 164,996 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2021-05-26 | 2021-05-27 | 1,231,204 | $30.53 | $37.59M | 543,113 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-05-25 | 2021-05-27 | 552,520 | $8.00 | $4.42M | 5,947,829 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2021-05-25 | 2021-05-27 | 135,000 | $30.93 | $4.18M | 1,774,317 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | J Other | 2021-05-06 | 2021-05-10 | 1,085,784 | — | $0 | 3,422,549 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-03-11 | 2021-03-15 | 1,250,000 | — | $0 | 6,500,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 1,450,000 | $11.75 | $17.04M | 7,750,349 | SEC↗ |
| RVMD Revolution Medicines, Inc. | J Other | 2021-02-24 | 2021-02-26 | 1,500,000 | — | $0 | 5,524,031 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | J Other | 2021-02-04 | 2021-02-08 | 914,216 | — | $0 | 4,508,333 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-14 | 2021-01-14 | 1,965,294 | $41.00 | $80.58M | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 7,412 | $44.73 | $331.5K | 7,739,918 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 4,782 | $44.73 | $213.9K | 1,965,294 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 2,791 | $44.00 | $122.8K | 1,970,076 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 27,650 | $42.12 | $1.16M | 1,972,867 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 5,630 | $41.08 | $231.3K | 2,000,517 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 805,050 | $40.01 | $32.21M | 2,006,147 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 4,325 | $44.00 | $190.3K | 7,747,330 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 42,860 | $42.12 | $1.81M | 7,751,655 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 8,727 | $41.08 | $358.5K | 7,794,515 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 1,247,873 | $40.01 | $49.93M | 7,803,242 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-12 | 2021-01-14 | 1,500,000 | $40.00 | $60.00M | 9,051,115 | SEC↗ |
| RVMD Revolution Medicines, Inc. | J Other | 2020-12-02 | 2020-12-04 | 1,000,000 | — | $0 | 7,024,031 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 15,000 | $7.01 | $105.2K | 9,200,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-11-17 | 2020-11-19 | 15,000 | $7.25 | $108.8K | 9,215,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2020-11-11 | 2020-11-13 | 1,000,000 | — | $0 | 9,230,349 | SEC↗ |
| RVMD Revolution Medicines, Inc. | J Other | 2020-09-09 | 2020-09-11 | 1,000,000 | — | $0 | 8,024,031 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 39,216 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 4,508,333 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 875,000 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 39,216 | — | $0 | 5,422,549 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 875,000 | — | $0 | 875,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 4,508,333 | — | $0 | 5,383,333 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 61,881 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 61,881 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 9,920,455 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 35,404,286 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 2,793,770 | — | $0 | 2,793,770 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 17,427 | — | $0 | 9,987,881 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 17,427 | — | $0 | 2,811,197 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 9,970,454 | — | $0 | 9,970,454 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 9,285 | — | $0 | 9,285 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 15,250,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 39,750,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 5,559,440 | — | $0 | 5,839,160 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 2,132,867 | — | $0 | 2,132,867 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 342,505 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 8,220,641 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 49,879 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 1,909,317 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 8,613,025 | — | $0 | 9,024,031 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 1,909,317 | — | $0 | 1,909,317 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion deriv | 2019-07-22 | 2019-07-22 | 39,166,667 | — | $0 | 0 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2019-07-22 | 2019-07-22 | 81,250 | $16.00 | $1.30M | 5,962,202 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion | 2019-07-22 | 2019-07-22 | 5,595,238 | — | $0 | 5,880,952 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | J Other | 2018-09-19 | 2018-09-19 | 1,500,000 | — | $0 | 6,391,176 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | J Other | 2018-08-30 | 2018-09-04 | 1,000,000 | — | $0 | 2,981,437 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | X Exercise deriv | 2018-08-22 | 2018-08-24 | 51,032 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | X Exercise | 2018-08-22 | 2018-08-24 | 51,032 | $1.55 | $79.1K | 3,034,083 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 1,000,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 11,000,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 10,650,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 1,086,411 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 2,285,640 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 3,107,930 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | P Buy | 2018-07-23 | 2018-07-24 | 266,667 | $15.00 | $4.00M | 2,983,051 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion | 2018-07-23 | 2018-07-24 | 2,705,334 | — | $0 | 2,716,384 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion deriv | 2018-06-29 | 2018-07-03 | 1,708,185 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion deriv | 2018-06-29 | 2018-07-03 | 45,000,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion | 2018-06-29 | 2018-07-03 | 341,637 | — | $0 | 9,741,636 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion | 2018-06-29 | 2018-07-03 | 8,999,999 | — | $0 | 9,399,999 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | J Other | 2018-06-20 | 2018-06-21 | 1,500,000 | — | $0 | 7,891,176 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2018-06-14 | 2018-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2018-03-07 | 2018-03-07 | 2,000,000 | — | $0 | 885,104 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2018-01-03 | 2018-01-05 | 816,326 | $42.00 | $34.29M | 680,272 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2017-12-06 | 2017-12-08 | 2,000,000 | — | $0 | 2,885,104 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | C Conversion deriv | 2017-11-06 | 2017-11-06 | 6,122,448 | — | $0 | 0 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | C Conversion deriv | 2017-11-06 | 2017-11-06 | 4,629,630 | — | $0 | 0 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | P Buy | 2017-11-06 | 2017-11-06 | 215,000 | $14.00 | $3.01M | 2,790,964 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | C Conversion | 2017-11-06 | 2017-11-06 | 2,575,964 | — | $0 | 2,575,964 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | J Other | 2017-10-18 | 2017-10-19 | 1,000,000 | — | $0 | 3,320,348 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-11 | 9,479,502 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-11 | 26,868,642 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-11 | 3,963,810 | — | $0 | 3,981,437 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2017-09-28 | 2018-02-13 | 2,000,000 | — | $0 | 4,885,104 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2017-09-28 | 2017-09-29 | 2,000,000 | — | $0 | 4,885,104 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-26 | 2017-09-27 | 400,000 | $43.00 | $17.20M | 6,885,104 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-25 | 2017-09-27 | 201,400 | $43.00 | $8.66M | 7,285,104 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-11 | 2017-09-12 | 20,000 | $44.25 | $885.0K | 57,651 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-08 | 2017-09-12 | 200,350 | $41.00 | $8.21M | 7,487,404 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-08 | 2017-09-12 | 900 | $42.39 | $38.2K | 7,486,504 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | J Other | 2017-07-13 | 2017-07-13 | 850,000 | — | $0 | 4,320,348 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2017-06-29 | 2017-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2017-06-14 | 2017-06-16 | 1,000,000 | — | $0 | 2,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2017-05-17 | 2017-05-19 | 1,000,000 | — | $0 | 3,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2017-04-18 | 2017-05-19 | 1,708 | — | $0 | 163,996 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | J Other | 2017-04-12 | 2017-04-14 | 920,000 | — | $0 | 9,391,176 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2017-04-11 | 2017-05-19 | 50,000 | — | $0 | 165,704 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2017-04-06 | 2017-04-06 | 2,000,000 | — | $0 | 4,475,191 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2017-03-30 | 2017-04-03 | 850,000 | — | $0 | 7,687,754 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2017-03-27 | 2017-03-27 | 650,000 | $18.00 | $11.70M | 5,170,348 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2017-03-23 | 2017-03-27 | 1,000,000 | $17.00 | $17.00M | 5,820,348 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-03-16 | 2017-03-20 | 24,800 | $40.74 | $1.01M | 116,444 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-03-16 | 2017-03-20 | 5,200 | $41.55 | $216.1K | 111,244 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | J Other | 2017-03-15 | 2017-03-16 | 850,000 | — | $0 | 6,820,348 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 10,900 | $28.73 | $313.2K | 146,208 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 7,279 | $27.69 | $201.6K | 157,108 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 1,000,000 | $25.50 | $25.50M | 285,713 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 1,000,000 | $25.50 | $25.50M | 6,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 27,115 | $26.95 | $730.7K | 164,387 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2017-02-27 | 2017-02-28 | 1,000,000 | — | $0 | 3,453,753 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-02-07 | 2017-02-09 | 1,000,000 | $35.28 | $35.28M | 4,453,753 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-03 | 11,250,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-03 | 35,750,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-03 | 9,688,344 | — | $0 | 10,230,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-03 | 3,048,780 | — | $0 | 3,048,780 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | J Other | 2016-12-19 | 2016-12-21 | 750,000 | — | $0 | 10,311,176 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2016-12-14 | 2016-12-16 | 2,000,000 | — | $0 | 7,475,191 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2016-11-29 | 2016-12-01 | 850,000 | — | $0 | 8,537,754 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2016-11-14 | 2016-11-16 | 1,000,000 | $19.36 | $19.36M | 9,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2016-11-14 | 2016-11-16 | 1,000,000 | $19.36 | $19.36M | 1,285,713 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | J Other | 2016-11-07 | 2016-11-09 | 1,000,000 | — | $0 | 7,670,348 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2016-11-03 | 2016-11-07 | 2,000,000 | — | $0 | 10,475,191 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2016-08-19 | 2016-08-19 | 1,000,000 | — | $0 | 2,892,916 | SEC↗ |
| EDIT Editas Medicine, Inc. | J Other | 2016-08-16 | 2016-08-16 | 750,000 | — | $0 | 3,906,176 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2016-06-15 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | S Sale | 2016-05-16 | 2016-05-18 | 850,000 | $31.25 | $26.56M | 3,892,916 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2016-04-14 | 2016-04-15 | 1,200,000 | — | $0 | 5,453,753 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 222,222 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 6,628,542 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 5,255,300 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-08 | 4,656,176 | — | $0 | 4,656,176 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 220,387 | — | $0 | 220,387 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 739,306 | — | $0 | 6,653,753 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 220,387 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 40,290 | — | $0 | 40,290 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 40,290 | — | $0 | 40,290 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 40,290 | — | $0 | 40,290 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | C Conversion deriv | 2015-11-16 | 2015-11-18 | 45,000,000 | — | $0 | 0 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | C Conversion | 2015-11-16 | 2015-11-18 | 10,588,235 | — | $0 | 11,061,176 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 109,832 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 1,700,000 | — | $0 | 4,742,916 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 109,832 | — | $0 | 109,832 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 15,986 | — | $0 | 65,226 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 15,986 | — | $0 | 65,227 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion deriv | 2015-11-03 | 2015-11-05 | 5,500,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion deriv | 2015-11-03 | 2015-11-05 | 32,500,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion | 2015-11-03 | 2015-11-05 | 8,843,537 | — | $0 | 9,387,754 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion | 2015-11-03 | 2015-11-05 | 1,496,598 | — | $0 | 1,496,598 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-23 | 565,037 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-23 | 8,105,314 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion | 2015-10-14 | 2015-10-23 | 8,670,351 | — | $0 | 8,670,351 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 150,546 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 150,546 | — | $0 | 150,546 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 2,330,157 | — | $0 | 6,442,916 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 21,910 | — | $0 | 49,241 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 21,910 | — | $0 | 49,240 | SEC↗ |
| GBT Global Blood Therapeutics, | C Conversion deriv | 2015-08-17 | 2015-08-19 | 8,000,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | C Conversion deriv | 2015-08-17 | 2015-08-19 | 41,663,168 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | C Conversion | 2015-08-17 | 2015-08-19 | 2,285,713 | — | $0 | 2,285,713 | SEC↗ |
| GBT Global Blood Therapeutics, | C Conversion | 2015-08-17 | 2015-08-19 | 11,903,763 | — | $0 | 12,475,191 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-07-23 | 2015-07-24 | 479,081 | — | $0 | 479,081 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-07-23 | 2015-07-24 | 1,200,000 | — | $0 | 2,002,045 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-07-23 | 2015-07-24 | 479,081 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 64,607 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 9,403 | — | $0 | 27,331 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 9,402 | — | $0 | 27,330 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 64,607 | — | $0 | 64,607 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 1,000,000 | — | $0 | 8,773,073 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-05-15 | 2015-05-18 | 1,000,000 | — | $0 | 3,202,045 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-05-15 | 2015-05-18 | 443,935 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-05-15 | 2015-05-18 | 443,935 | — | $0 | 443,935 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2015-05-14 | 2015-05-15 | 312,498 | — | $0 | 312,498 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2015-05-14 | 2015-05-15 | 312,498 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2015-05-14 | 2015-05-15 | 828,456 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion deriv | 2015-05-05 | 2015-05-12 | 1,328,502 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion deriv | 2015-05-05 | 2015-05-12 | 7,833,333 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion deriv | 2015-05-05 | 2015-05-12 | 30,000,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion | 2015-05-05 | 2015-05-12 | 5,454,545 | — | $0 | 5,727,272 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion | 2015-05-05 | 2015-05-12 | 241,545 | — | $0 | 7,393,059 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion | 2015-05-05 | 2015-05-12 | 1,424,242 | — | $0 | 7,151,514 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-03-24 | 2015-03-25 | 346,658 | — | $0 | 346,658 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-03-24 | 2015-03-25 | 346,658 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-03-24 | 2015-03-25 | 1,400,000 | — | $0 | 4,202,045 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-27 | 2015-01-28 | 1,255,177 | — | $0 | 9,773,073 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-27 | 2015-01-28 | 81,094 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-27 | 2015-01-28 | 81,094 | — | $0 | 81,094 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-16 | 2015-01-20 | 652,758 | — | $0 | 11,028,250 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-16 | 2015-01-20 | 42,173 | — | $0 | 42,173 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-16 | 2015-01-20 | 42,173 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 32,500,000 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 2,499,999 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 295,194 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 793,650 | — | $0 | 11,587,296 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 93,712 | — | $0 | 11,681,008 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 10,317,457 | — | $0 | 10,793,646 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 22,250,770 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 8,263,595 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 4,666,478 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 1,315,859 | — | $0 | 4,858,975 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 743,070 | — | $0 | 5,602,045 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 3,543,116 | — | $0 | 3,543,116 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2014-05-12 | 2014-05-12 | 120,577 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2014-05-12 | 2014-05-12 | 17,462 | — | $0 | 17,462 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2014-05-12 | 2014-05-12 | 120,577 | — | $0 | 120,577 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2014-05-12 | 2014-05-12 | 1,642,411 | — | $0 | 4,927,234 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2014-03-20 | 2014-03-24 | 16,143 | — | $0 | 16,143 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 127,077 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 20,750,000 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 3,058,281 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 82,989 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 481,619 | — | $0 | 4,080,043 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | P Buy | 2014-02-11 | 2014-02-13 | 551,482 | — | $0 | 4,841,591 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 127,077 | $0.06 | $7.6K | 4,207,120 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 82,989 | — | $0 | 4,290,109 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 3,267,716 | — | $0 | 3,598,424 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 1,106,194 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 23,772,388 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion | 2013-09-30 | 2013-10-02 | 5,943,097 | — | $0 | 6,293,097 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion | 2013-09-30 | 2013-10-02 | 276,548 | — | $0 | 6,569,645 | SEC↗ |